“Multi-Targeted Tyrosine Kinase Inhibitor Sorafenib. Application Experience in Kidney Cancer With Lung Metastases”. Voprosy onkologii 62, no. 1 (December 15, 2016): 154–156. Accessed October 14, 2026. https://voprosyonkologii.ru/index.php/journal/article/view/240.